Page last updated: 2024-10-24

calcium-dependent cysteine-type endopeptidase activity

Definition

Target type: molecularfunction

Catalysis of the hydrolysis of nonterminal peptide bonds in a polypeptide chain by a mechanism using a cysteine residue at the enzyme active center, and requiring the presence of calcium. [GOC:mah]

Calcium-dependent cysteine-type endopeptidase activity is a molecular function that involves the enzymatic cleavage of peptide bonds within proteins. This activity is specifically characterized by its dependence on calcium ions (Ca2+) for optimal function and its use of a cysteine residue as the catalytic nucleophile within the active site of the enzyme.

**Key Features:**

- **Calcium Dependence:** Calcium ions play a crucial role in the activity of these enzymes by binding to specific sites on the protein, often within the active site. This binding event induces conformational changes that are essential for proper substrate recognition and catalysis.

- **Cysteine Nucleophile:** The active site of these endopeptidases contains a cysteine residue that acts as the nucleophile in the catalytic process. The sulfur atom of the cysteine side chain attacks the carbonyl carbon of the peptide bond, forming a covalent intermediate.

- **Hydrolysis:** Following the nucleophilic attack, the covalent intermediate is hydrolyzed by the addition of a water molecule. This step results in the cleavage of the peptide bond and the release of the cleaved peptide fragments.

**Biological Significance:**

Calcium-dependent cysteine-type endopeptidases are involved in a wide range of biological processes, including:

- **Proteolysis:** These enzymes contribute to the breakdown of proteins, playing a critical role in protein turnover, degradation of damaged or misfolded proteins, and activation of specific proteins by proteolytic processing.

- **Signal Transduction:** Some of these enzymes act as signaling molecules, participating in cellular communication pathways. They can cleave and activate or deactivate other proteins involved in signaling cascades.

- **Apoptosis:** These endopeptidases can be involved in programmed cell death (apoptosis) by cleaving proteins that are essential for cell survival, contributing to the disassembly and dismantling of the cell.

- **Development:** These enzymes are important during development, regulating cell differentiation and tissue morphogenesis.

**Examples:**

Examples of calcium-dependent cysteine-type endopeptidases include:

- **Calpains:** A family of cysteine proteases that are involved in a wide range of cellular processes, including muscle protein breakdown, cell signaling, and apoptosis.
- **Caspases:** A family of cysteine proteases that play a central role in apoptosis by cleaving specific proteins that regulate cell death pathways.
- **Cathepsins:** A group of lysosomal cysteine proteases that are involved in protein degradation within the lysosomes, contributing to intracellular protein turnover.

**Therapeutic Implications:**

The importance of calcium-dependent cysteine-type endopeptidases in various biological processes has led to their investigation as potential therapeutic targets for a range of diseases, including cancer, neurodegenerative diseases, and inflammatory disorders.

**Inhibitors:**

Specific inhibitors of these enzymes have been developed for both research and therapeutic purposes. These inhibitors can block the activity of these enzymes, potentially preventing or mitigating the pathological consequences associated with their dysregulation.'
"

Proteins (5)

ProteinDefinitionTaxonomy
Calpain-1 catalytic subunitA protein that is a translation product of the CAPN11 gene in chicken. [PRO:DNx, UniProtKB:P00789]Gallus gallus (chicken)
Calpain-9A calpain-9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O14815]Homo sapiens (human)
Calpain-2 catalytic subunitA calpain-2 catalytic subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:P17655]Homo sapiens (human)
Calpain-1 catalytic subunitA calpain-1 catalytic subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:P07384]Homo sapiens (human)
Calpain small subunit 1A calpain small subunit 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P04632]Homo sapiens (human)

Compounds (25)

CompoundDefinitionClassesRoles
celecoxiborganofluorine compound;
pyrazoles;
sulfonamide;
toluenes
cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
rofecoxibbutenolide;
sulfone
analgesic;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
isoquinoline-1,3,4-trioneisoquinoline-1,3,4-trione: structure in first source
aloxistatinaloxistatin : An L-leucine derivative that is the amide obtained by formal condensation of the carboxy group of (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylic acid with the amino group of N-(3-methylbutyl)-L-leucinamide.

aloxistatin: a membrane-permeable cysteine protease inhibitor
epoxide;
ethyl ester;
L-leucine derivative;
monocarboxylic acid amide
anticoronaviral agent;
cathepsin B inhibitor
carbobenzoxyvalylphenylalanine aldehydeZ-Val-Phe-H : A dipeptide resulting from the formal condensation of the carboxy group of N-benzyloxycarbonyl-L-valine with the amino group of L-phenylalanine aldehyde. It is a potent cell-permeable inhibitor of calpain I and II, and is also a gamma-secretase inhibitor.aldehyde;
carbamate ester;
dipeptide
antileishmanial agent;
apoptosis inhibitor;
EC 3.4.22.52 (calpain-1) inhibitor;
EC 3.4.22.53 (calpain-2) inhibitor;
EC 3.4.23.46 (memapsin 2) inhibitor
calpeptinamino acid amide
calpain inhibitor 2calpain inhibitor 2: inhibits degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and some other cysteine proteinasespeptide
n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamineN-(N-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine: inhibits calcium-activated neutral protease; see also record for E-64; RN given refers to (2-S-(2alpha,3beta)(R*)-isomer)leucine derivative
e 64E 64: cysteine protease inhibitor of microbial origin, which inhibits cathepsin B (EC 3.4.22.1) and cathepsin L (EC 3.4.22.-)dicarboxylic acid monoamide;
epoxy monocarboxylic acid;
guanidines;
L-leucine derivative;
zwitterion
antimalarial;
antiparasitic agent;
protease inhibitor
acetylleucyl-leucyl-norleucinalacetylleucyl-leucyl-norleucinal : A tripeptide composed of N-acetylleucyl, leucyl and norleucinal residues joined in sequence.

acetylleucyl-leucyl-norleucinal: a proteasome inhibitor
aldehyde;
tripeptide
cysteine protease inhibitor
benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde: proteasome inhibitor

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal : A tripeptide that is L-leucyl-L-leucyl-L-leucine in which the C-terminal carboxy group has been reduced to the corresponding aldehyde and the N-terminal amino group is protected as its benzyloxycarbonyl derivative.
amino aldehyde;
carbamate ester;
tripeptide
proteasome inhibitor
5-Nitroisatinindolesanticoronaviral agent
benzyloxycarbonyl-phe-ala-fluormethylketonecathepsin B inhibitor : A cysteine protease inhibitor which inhibits cathepsin B (EC 3.4.22.1).
3-deoxysappanchalcone2'-O-methylisoliquiritigenin : A member of the class of chalcones that is isoliquiritigenin in which one of the hydroxy groups at position 2' is replaced by a methoxy group.

3-deoxysappanchalcone: Anti-allergic from the roots and heartwood of Caesalpinia sappan; structure in first source
chalcones;
monomethoxybenzene;
phenols
metabolite
z-val-ala-asp(ome)-fluoromethylketoneZ-Val-Ala-Asp(OMe)-CH2F : A tripeptide consisting of Z-Val-Ala-Asp(OMe) in which the C-terminal OH group has been replaced by a fluoromethyl group. An irreversible pan-caspase inhibitor.

z-Val-Ala-Asp(Ome)-fluoromethylketone: confuse with Z-VAD-FMK
carbamate ester;
organofluorine compound;
tripeptide
apoptosis inhibitor;
protease inhibitor
snj-1945((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester: calpain inhibitor
phenylalanyl-valineVal-Phe : A dipeptide formed from L-valine and L-phenylalanine residues.dipeptidemetabolite
ca 074
a-705253A-705253: structure in first source
sja 6017N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal: structure in first source
phevalinphevalin : A member of the class of pyrazinones that is pyrazin-2(1H)-one substituted by an isopropyl and benzyl groups at position 3 and 6, respectively. It is a natural product found in Staphylococcus aureus that inhibits calpain in a casein hydrolysis assay (IC50 = 1.3 muM), contributes to S. aureus infection in mice, and alters human keratinocyte gene expression.

phevalin: isolated from a Streptomyces sp.; structure given in first source
benzenes;
pyrazinone
bacterial metabolite;
calpain inhibitor
calpain inhibitor iiicalpain inhibitor III: potential anticataract drug
PF-00835231PF-00835231 : A primary alcohol resulting from the cleavage of the phosphate group of the prodrug PF-07304814. It is an inhibitor of SARS-CoV-1 and -2 main protease (3CLpro) and exhibits potent in vitro antiviral activity.aromatic ether;
indolecarboxamide;
L-leucine derivative;
primary alcohol;
pyrrolidin-2-ones;
secondary carboxamide
anticoronaviral agent;
drug metabolite;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
grassystatin agrassystatin A: isolated from a cyanobacterium, identified as Lyngbya cf.; structure in first source
N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamideN-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 1H-indole-2-carboxylic acid with the primary amino group of 3-cyclohexyl-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide. It is an inhibitor of SARS coronavirus main proteinase and inhibits SARS-CoV-2 replication in cell culture (EC50 = 0.53 muM).aldehyde;
indolecarboxamide;
oligopeptide;
pyrrolidin-2-ones;
secondary carboxamide
anticoronaviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor